Related Experiment Videos
EFFECT OF CHLORPROTHIXENE IN PATIENTS WITH PARANOID SYMPTOMS
Canadian Medical Association Journal
|October 5, 1963
Summary
Chlorprothixene, a thioxanthine derivative, effectively treated paranoid symptoms in female patients. It demonstrated comparable efficacy to chlorpromazine with fewer adverse effects.
Area of Science:
- Psychopharmacology
- Neuroscience
Background:
- Thioxanthine derivatives, like chlorprothixene, are investigated for broad-spectrum antipsychotic properties.
- Phenothiazine derivatives are established treatments for psychosis.
Purpose of the Study:
- To compare the efficacy and side effect profile of chlorprothixene with phenothiazine derivatives in treating paranoid symptoms.
- To evaluate chlorprothixene's effectiveness in a clinical psychiatric setting.
Main Methods:
- A comparative study involving 32 female patients with paranoid symptoms.
- Administration of high dosage ranges of chlorprothixene (200-1200 mg daily) and chlorpromazine.
- Assessment of symptom control and side effects.
Main Results:
- Chlorprothixene was found to be as effective as chlorpromazine in controlling paranoid symptoms.
- Fewer side effects were observed with chlorprothixene treatment compared to chlorpromazine.
- The study was conducted in a psychiatric admission service and aftercare clinic setting.
Conclusions:
- Chlorprothixene is an effective antipsychotic agent for managing paranoid symptoms.
- Chlorprothixene offers a favorable side effect profile compared to chlorpromazine, suggesting its potential as an alternative treatment.